Biomarkers of NNK in prediction of lung cancer development in smokers
NNK 生物标志物预测吸烟者肺癌的发展
基本信息
- 批准号:8399450
- 负责人:
- 金额:$ 49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-13 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer death in the United States and worldwide. Cigarette smoking causes approximately 90 percent of lung cancer. However, approximately only 15 percent of lifelong smokers develop lung cancer over their lifetimes. The variation in the susceptibility to lung cancer among smokers not only depends on their exposure to tobacco carcinogens, but also upon genetic, dietary, and other environmental factors. Tobacco- specific nitrosamines (i.e., NNK) in cigarette smoke is among the most important carcinogens that cause lung cancer in humans. The proposed study is to assess the role of validated urinary biomarkers for the uptake and metabolism of NNK in prediction of lung cancer development among current smokers. The proposed study will utilize two established residential cohorts of Chinese. The Shanghai Cohort Study enrolled 18,244 men aged 45-64 years in Shanghai, China, during 1986-89. The Singapore Chinese Health Study enrolled 27,959 men and 35,298 women aged 45-74 years during 1993-98. At recruitment, all cohort members provided detailed dietary and medical histories. Blood and urine specimens were collected from all Shanghai cohort members and about 60 percent of Singapore cohort members. The cohorts have been followed for the occurrence of cancer and death through routine ascertainment approaches. By the end of 2012, a total of 1317 incident lung cancer cases will be expected in the two cohorts. An equal number of controls will be randomly chosen among the two cohorts for proposed studies. We will measure the concentrations of NNAL and NNAL-Glucs (NNK metabolites), total nicotine equivalents (i.e., the sum of nicotine, cotinine, trans-32-hydroxycotinine and their corresponding glucuronides), and total isothiocyanates in urine, and beta-cryptoxanthin and other dietary antioxidants in serum on all study subjects. Genetic polymorphisms in NNK- and nicotine-metabolizing genes also will be determined. The specific aims are (1) to determine if total NNAL and NNAL-Glucs:NNAL ratio in prediagnostic urines differ between those who develop lung cancer and those who remain free of cancer, but are otherwise comparable in terms of age, gender, date of study enrollment, smoking status, intensity and duration over lifetime, and urinary total nicotine equivalents; and (2) to determine if genetic polymorphisms in NNK- and nicotine-metabolizing genes and dietary factors modify the association between NNK biomarkers and development of lung cancer. The ultimate goal of the proposed research is the development of an effective set of non-invasive, predictive markers of lung cancer development that allow for the identification, among smokers, of the relatively small fraction of individuals who are at very high risk for lung cancer. People with high risk for lung cancer could be closely followed for early detection of lung cancer and encouraged to change their lifestyles, e.g., quitting smoking. In addition, chemopreventive agents, if available, could be prescribed to high-risk people for protection against lung cancer development.
描述(由申请人提供):肺癌是美国和全世界癌症死亡的主要原因。吸烟导致大约90%的肺癌。然而,大约只有15%的终身吸烟者在其一生中患上肺癌。吸烟者对肺癌易感性的差异不仅取决于他们对烟草致癌物的暴露,还取决于遗传、饮食和其他环境因素。烟草特有的亚硝胺(即,香烟烟雾中的NNK)是导致人类肺癌的最重要的致癌物质之一。该研究旨在评估经验证的尿液生物标志物对NNK的吸收和代谢在预测当前吸烟者肺癌发展中的作用。拟议的研究将利用两个已建立的中国居民队列。上海队列研究于1986年至1989年期间在中国上海招募了18,244名年龄在45-64岁之间的男性。新加坡华人健康研究在1993- 1998年间招募了27,959名男性和35,298名女性,年龄在45-74岁之间。在招募时,所有队列成员都提供了详细的饮食和病史。从所有上海队列成员和约60%的新加坡队列成员中采集血液和尿液标本。通过常规确认方法对队列进行了癌症和死亡发生率的随访。到2012年底,预计这两个队列中将有1317例肺癌病例。将在两个队列中随机选择相同数量的对照组用于拟定研究。我们将测量NNAL和NNAL-葡糖(NNK代谢物)、总尼古丁当量(即,尼古丁、可替宁、反式-32-羟基可替宁及其相应的葡萄糖醛酸苷的总和)和尿液中的总异硫氰酸酯,以及所有研究受试者血清中的β-隐黄素和其他膳食抗氧化剂。还将确定NNK和尼古丁代谢基因的遗传多态性。具体目的是(1)确定诊断前尿液中的总NNAL和NNAL-Glucs:NNAL比值在发生肺癌的患者和未发生癌症的患者之间是否存在差异,但在年龄、性别、研究入组日期、吸烟状态、一生中的强度和持续时间以及尿总尼古丁当量方面是否具有可比性;以及(2)确定NNK和尼古丁代谢基因的遗传多态性和饮食因素是否改变了NNK生物标志物与肺癌发生之间的关联。拟议研究的最终目标是开发一套有效的非侵入性肺癌发展预测标志物,以便在吸烟者中识别相对较小比例的肺癌高危人群。肺癌高危人群可被密切跟踪,以便及早发现肺癌,并鼓励他们改变生活方式,例如,戒烟。此外,化学预防剂,如果可用的话,可以开给高危人群,以防止肺癌的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jian-Min Yuan其他文献
Jian-Min Yuan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jian-Min Yuan', 18)}}的其他基金
Randomized Clinical Trial of Lung Cancer Chemoprevention with Sulforaphane in Former Smokers
前吸烟者用萝卜硫素化学预防肺癌的随机临床试验
- 批准号:
9380009 - 财政年份:2017
- 资助金额:
$ 49万 - 项目类别:
Randomized Clinical Trial of Lung Cancer Chemoprevention with Sulforaphane in Former Smokers
前吸烟者用萝卜硫素化学预防肺癌的随机临床试验
- 批准号:
9927598 - 财政年份:2017
- 资助金额:
$ 49万 - 项目类别:
Translational Research Training in Cancer Etiology and Prevention
癌症病因学和预防的转化研究培训
- 批准号:
9318470 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
Translational Research Training inCancer Etiology & Prevention
癌症病因学转化研究培训
- 批准号:
10673621 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
Translational Research Training inCancer Etiology & Prevention
癌症病因学转化研究培训
- 批准号:
10223215 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
Cancer epidemiology cohorts in Shanghai and Singapore
上海和新加坡的癌症流行病学队列
- 批准号:
8762819 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
Translational Research Training in Cancer Etiology and Prevention
癌症病因学和预防的转化研究培训
- 批准号:
8904639 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
Translational Research Training inCancer Etiology & Prevention
癌症病因学转化研究培训
- 批准号:
9889044 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
Translational Research Training inCancer Etiology & Prevention
癌症病因学转化研究培训
- 批准号:
10441301 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
相似国自然基金
环状RNA介导DNA损伤-炎症通路调控NNK
诱导的肺癌发生
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
NNK 调控 DNMT1 介导的 RCOR1 甲基化对 口腔鳞状细胞癌细胞干性影响的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:10.0 万元
- 项目类别:省市级项目
隧道纳米管介导的自噬流传递:烟草致癌物NNK促进杀伤性T细胞失能加速胰腺癌免疫逃逸新机制
- 批准号:82372895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
吸烟致癌新机制:烟草化合物NNK通过β2AR/SOX4/Akt轴改变腺泡命运诱导胰腺癌发生
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪酸受体CD36对烟草致癌物NNK诱导肺癌α7nAChR信号通路的调控
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
长链非编码RNAABHD11-AS1通过miR-182-5p/Tiam1-Rac1轴介导烟草致癌物NNK诱导肺癌发生的作用与机制
- 批准号:82073579
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
QKI甲基化介导circPRMT10生成在NNK致肺癌发生中的作用机制研究
- 批准号:82003488
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
NNK诱导胰腺癌发生的研究:LncRNA LINC00857-Wnt/β-catenin通路改变腺泡命运
- 批准号:81872008
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
烟草致癌物NNK诱发长链非编码RNA基因突变在肺癌发生中的作用
- 批准号:81472937
- 批准年份:2014
- 资助金额:75.0 万元
- 项目类别:面上项目
PPARγ外源激动剂早期干预NNK诱导肺癌干细胞中15-LOX表达调控的机制
- 批准号:81472742
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
相似海外基金
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
- 批准号:
10512091 - 财政年份:2022
- 资助金额:
$ 49万 - 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
- 批准号:
10683294 - 财政年份:2022
- 资助金额:
$ 49万 - 项目类别:
Project 2 - 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) α-Hydroxy Glucuronides, Metabolic Profiling and Activation
项目 2 - 4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁酮 (NNK) α-羟基葡萄糖醛酸、代谢分析和激活
- 批准号:
9149449 - 财政年份:2010
- 资助金额:
$ 49万 - 项目类别:
Biomarkers of NNK in prediction of lung cancer development in smokers
NNK 生物标志物预测吸烟者肺癌的发展
- 批准号:
7729808 - 财政年份:2009
- 资助金额:
$ 49万 - 项目类别:
Nicotine and NNK Glucuronidation Pathways on Smokers
吸烟者的尼古丁和 NNK 葡萄糖醛酸化途径
- 批准号:
7786635 - 财政年份:2009
- 资助金额:
$ 49万 - 项目类别:
Biomarkers of NNK in prediction of lung cancer development in smokers
NNK 生物标志物预测吸烟者肺癌的发展
- 批准号:
8269126 - 财政年份:2009
- 资助金额:
$ 49万 - 项目类别:
Biomarkers of NNK in prediction of lung cancer development in smokers
NNK 生物标志物预测吸烟者肺癌的发展
- 批准号:
8519949 - 财政年份:2009
- 资助金额:
$ 49万 - 项目类别:
Biomarkers of NNK in prediction of lung cancer development in smokers
NNK 生物标志物预测吸烟者肺癌的发展
- 批准号:
8080473 - 财政年份:2009
- 资助金额:
$ 49万 - 项目类别:
Biomarkers of NNK in prediction of lung cancer development in smokers
NNK 生物标志物预测吸烟者肺癌的发展
- 批准号:
7892471 - 财政年份:2009
- 资助金额:
$ 49万 - 项目类别: